Cargando…
3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs
Gastric cancer is a malignant tumor characterized by high morbidity and invasion. Surgery combined with chemo-radiotherapy is the most common treatment for gastric cancer, while multiple drug resistance always results in treatment failure. Once the anti-tumor drugs enter the tumor foci, tumor cells...
Autores principales: | Shi, Hui, Sun, Yaoxiang, Ruan, Hongru, Ji, Cheng, Zhang, Jiahui, Wu, Peipei, Li, Linli, Huang, Chihan, Jia, Yuanwang, Zhang, Xu, Xu, Wenrong, Jiang, Jiajia, Qian, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024625/ https://www.ncbi.nlm.nih.gov/pubmed/33842314 http://dx.doi.org/10.3389/fonc.2021.603533 |
Ejemplares similares
-
Anti-cancer drug 3,3′-diindolylmethane activates Wnt4 signaling to enhance gastric cancer cell stemness and tumorigenesis
por: Zhu, Yanhua, et al.
Publicado: (2016) -
3,3′-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing
por: Shi, Hui, et al.
Publicado: (2017) -
3,3'-Diindolylmethane induces gastric cancer cells death via STIM1 mediated store-operated calcium entry
por: Ye, Yang, et al.
Publicado: (2021) -
A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth
por: Yin, Xiao-Fei, et al.
Publicado: (2012) -
Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction
por: Jaffry, Uzma, et al.
Publicado: (2023)